835 related articles for article (PubMed ID: 25394527)
1. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
3. Assessed value of high-sensitivity cardiac troponin T for cardiovascular disease among CKD patients.
Sun L; Tan X; Cao X; Zou J
Ren Fail; 2016 Jun; 38(5):728-37. PubMed ID: 26984066
[TBL] [Abstract][Full Text] [Related]
4. Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients.
Caliskan Y; Ozkok A; Akagun T; Alpay N; Guz G; Polat N; Tufan F; Ecder T; Bozfakioglu S
Kidney Blood Press Res; 2012; 35(5):340-8. PubMed ID: 22473007
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
6. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease.
Bjurman C; Petzold M; Venge P; Farbemo J; Fu ML; Hammarsten O
Clin Biochem; 2015 Mar; 48(4-5):302-7. PubMed ID: 25637776
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
8. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M
Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
[TBL] [Abstract][Full Text] [Related]
9. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac markers in different degrees of chronic kidney disease: influence of inflammation and previous heart disease].
Quiroga B; Goicoechea M; García de Vinuesa S; Verde E; Verdalles U; Yuste C; Reque J; Luño J
Med Clin (Barc); 2012 Jun; 139(3):98-102. PubMed ID: 21807382
[TBL] [Abstract][Full Text] [Related]
11. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
12. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
13. Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.
Sathi S; Mahapatra H; Sunder S; Jayaraman R; Sharma N; Verma H; Krishnamoorthy V; Gupta A; Kanchi P; Daksh S; Pursnani L; Shadab F; Singh M
Nephrourol Mon; 2014 Nov; 6(6):e22112. PubMed ID: 25738114
[TBL] [Abstract][Full Text] [Related]
14. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M
Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
[TBL] [Abstract][Full Text] [Related]
16. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
[TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
Sommerer C; Giannitsis E; Schwenger V; Zeier M
Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
[TBL] [Abstract][Full Text] [Related]
18. Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease--preliminary data.
Lai S; Mariotti A; Coppola B; Lai C; Aceto P; Dimko M; Galani A; Innico G; Frassetti N; Mangiulli M; Cianci R
Eur Rev Med Pharmacol Sci; 2014; 18(7):1010-7. PubMed ID: 24763881
[TBL] [Abstract][Full Text] [Related]
19. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
Apple FS; Murakami MM; Pearce LA; Herzog CA
Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
[TBL] [Abstract][Full Text] [Related]
20. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
